Training program to understand Alzheimer's disease using big data
Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)
['FUNDING_TRAINING'] · EMORY UNIVERSITY · NIH-10934116
This program is designed to help students learn about Alzheimer's disease by combining big data analysis with biological research, so they can find better ways to diagnose and treat the condition and improve the lives of those affected by it.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10934116 on ClinicalTrials.gov |
What this research studies
This program aims to train pre- and post-doctoral students in the complexities of Alzheimer's disease (AD) by integrating big data science with biological studies. It focuses on understanding the various factors that influence the risk and progression of AD, including genetic and environmental influences. Participants will gain skills in analyzing large datasets to develop better diagnostic tools and interventions for AD and related disorders. The training will emphasize a holistic approach to dementia research, preparing trainees to make significant contributions to the field.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, including those with a family history or other risk factors.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any risk factors for the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and treatments for Alzheimer's disease, benefiting patients and their caregivers.
How similar studies have performed: Previous research using big data approaches in Alzheimer's disease has shown promise, indicating that this method could lead to significant advancements in understanding and treating the condition.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOLDE, TODD E — EMORY UNIVERSITY
- Study coordinator: GOLDE, TODD E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease